Does a patient on Eliquis (apixaban) for Deep Vein Thrombosis (DVT) with a history of Coronary Artery Disease (CAD) and a stent also need to be on aspirin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antiplatelet Therapy for DVT Patients with CAD and Stent on Apixaban

Yes, this patient should be on aspirin in addition to Eliquis (apixaban), but only if they are within 12 months of their stent placement or have had a recent acute coronary syndrome; after this period, most patients can safely discontinue aspirin and continue anticoagulation alone.

Time-Based Decision Algorithm

Within 12 Months of Stent Placement

Continue dual therapy (apixaban + aspirin) for patients who are still within the guideline-recommended period after coronary stenting 1. The European Society of Cardiology recommends:

  • Standard DAPT duration: 6 months for stable CAD with stent, 12 months for acute coronary syndrome 1
  • After DAPT completion: Lifelong single antiplatelet therapy (usually aspirin 75-100 mg daily) is recommended for all patients with prior stent placement 1, 2, 3

Beyond 12 Months Post-Stent (Remote Stenting)

Discontinue aspirin and continue apixaban alone for most patients 4. The 2020 ACC Expert Consensus specifically addresses this scenario:

  • For patients with remote coronary stenting (>12 months) who require anticoagulation for VTE, stop all antiplatelet therapy and treat with oral anticoagulation alone (DOAC preferred) 4
  • This approach reduces bleeding risk while maintaining adequate protection against both thrombotic complications 4

Critical Timing Considerations

If within 1-3 months of stent placement, the situation is more complex and requires triple therapy initially:

  • Triple antithrombotic therapy (apixaban + aspirin + clopidogrel) should be used for the shortest possible duration, typically 1 month maximum 5
  • After 1 month, transition to dual therapy with apixaban + single antiplatelet (clopidogrel preferred over aspirin) for up to 6-12 months 4, 5
  • Use low-dose aspirin (75-81 mg) if aspirin is chosen during combination therapy 4, 2

Bleeding Risk Assessment

High bleeding risk patients require modified approaches 1:

  • Consider shorter DAPT duration (3 months or even 1 month) after stenting 1
  • Transition to anticoagulation alone as soon as safely possible 4
  • Use proton pump inhibitors routinely during any combination antithrombotic therapy 5, 3

Common Pitfalls to Avoid

Do not continue triple therapy beyond 1 month unless there are exceptional high-ischemic-risk features (e.g., left main stenting, history of stent thrombosis), as bleeding risk substantially outweighs benefit 5. The PRECISE-DAPT score ≥25 identifies high bleeding risk patients who should have abbreviated combination therapy 1.

Do not use ticagrelor or prasugrel as part of triple antithrombotic therapy with anticoagulation—only clopidogrel should be used if a P2Y12 inhibitor is needed 5.

Avoid premature discontinuation of antiplatelet therapy within the first 6-12 months post-stent due to risks of stent thrombosis and recurrent MI 1.

Practical Implementation

For your specific patient on apixaban for DVT with CAD and stent history:

  1. Determine time since stent placement - this is the critical decision point
  2. If <12 months: Continue aspirin 75-100 mg daily + apixaban 1, 2, 3
  3. If >12 months: Discontinue aspirin, continue apixaban alone 4
  4. If 1-6 months and high bleeding risk: Consider clopidogrel instead of aspirin with apixaban 4, 5

The evidence strongly supports that remote stenting (>12 months) does not require continued antiplatelet therapy when full-dose anticoagulation is indicated for another condition like DVT 4. This represents a paradigm shift from older practices that maintained lifelong aspirin regardless of anticoagulation status.

Related Questions

A 60-year-old man, four days after cholecystectomy, presents with chest pain and an electrocardiogram showing ST‑segment elevation myocardial infarction. After receiving oxygen, morphine, aspirin, and nitroglycerin in the emergency department, what is the next appropriate management step?
What are the recommended doses and indications for ACE inhibitors and epoetin alfa (Eprel) in acute coronary syndrome?
What is the recommended immediate management for a patient with suspected acute coronary syndrome?
What is the management of Acute Coronary Syndrome (ACS) with concomitant hypertension in the emergency room?
What is the recommended management for a 37‑year‑old female with coronary artery disease status post left anterior descending (LAD) stent placement and mild tricuspid regurgitation who presents with shortness of breath and fatigue, including antiplatelet therapy, statin therapy, carvedilol dosing, lipid monitoring, thyroid testing, sleep study referral, and weight‑management strategies?
When is lithotripsy (extracorporeal shock wave lithotripsy) recommended for patients with kidney stones?
What exams and tests should be performed for a patient following reversal of a sigmoid colostomy?
Is it normal to lose the mucus plug at 29 weeks of gestation without other signs of labor and can it regenerate?
What are the considerations for using Elavil (amitriptyline) in patients with Coronary Artery Disease (CAD)?
Is it safe to use phentermine (an appetite suppressant) and Adderall (amphetamine and dextroamphetamine) concurrently?
What is the appropriate dosage of Neomycin (neomycin) eye drops for treating bacterial infections of the eye?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.